FUB-APINACA

FUB-APINACA
Systematic (IUPAC) name
	N-(adamantan-1-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
Clinical data
Legal status	CA: Schedule II;
Chemical data
Formula	C25H26FN3O
Molar mass	403.5 g/mol
	SMILES O=C(NC1(C[C@H]2C3)C[C@H]3C[C@H](C2)C1)C4=NN(CC5=CC=C(F)C=C5)C6=C4C=CC=C6 ;
	InChI InChI=1S/C25H26FN3O/c26-20-7-5-16(6-8-20)15-29-22-4-2-1-3-21(22)23(28-29)24(30)27-25-12-17-9-18(13-25)11-19(10-17)14-25/h1-8,17-19H,9-15H2,(H,27,30)/t17-,18+,19-,25? ; Key:MWBHSNBPUSKVDD-LPSAYFBNSA-N ;

FUB-APINACA (also known as FUB-AKB48) is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB₁ receptor and has been sold online as a designer drug.^[1] It is an analogue of APINACA and 5F-APINACA where the pentyl chain has been replaced with fluorobenzyl.

Legal status[edit]

Sweden's public health agency suggested classifying FUB-APINACA as a hazardous substance on November 10, 2014.^[2]

It is also illegal in Alabama (listed as FUB-AKB48).^[3]

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.